Full Press Release Details
kevzara sarilumab approved by fda as first and only biologic indicated for patients with polymyalgia rheumatica.
REGN
kevzara sarilumab approved by fda as first and only biologic indicated for patients with polymyalgia rheumatica
Key Takeaway: kevzara sarilumab approved by fda as first and only biologic indicated for patients with polymyalgia rheumatica